Skip to content

Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies

Research output: Contribution to journalArticle

  • M Schlosser
  • PW Mueller
  • C Törn
  • E Bonifacio
  • PJ Bingley
  • Laboratories Participating
Original languageEnglish
Pages (from-to)2611 - 2620
Number of pages10
JournalDiabetologia
Volume53(12)
DOIs
DatePublished - Dec 2010

Abstract

AIMS/HYPOTHESIS: Insulin autoantibodies (IAA) are important in type 1 diabetes risk assessment. However, their determination varies more between laboratories than other diabetes autoantibodies. The Diabetes Antibody Standardization Program (DASP) aims to improve and standardise measurement of autoantibodies associated with type 1 diabetes. We report the results of measurement of IAA from DASP workshops in 2002, 2003 and 2005. METHODS: Up to 32 laboratories in 14 countries participated in each workshop. Aliquots of coded sera from 50 patients with newly diagnosed type 1 diabetes and 100 blood donor controls were circulated to participating laboratories. Reported results were analysed using receiver operator characteristic (ROC) curves. We compared concordance of antibody levels by ranking, IAA and insulin antibody (IA) indices and units derived from an IA standard curve. RESULTS: In all three workshops IAA assay performance had improved compared with DASP 2000. The median area under the ROC curve was 0.73 in DASP 2002, 0.78 in 2003 and 0.80 in 2005 (p = 0.0012), and median laboratory-assigned sensitivity was 26% in 2002, 36% in 2003 and 45% in 2005 (p 

Documents

View research connections

Related faculties, schools or groups